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Dr Freemanr
doi:10.1016/j.jtcvs.2006.10.008bjective: Leak after esophageal anastomosis or perforation repair prolongs hospi-
alization, prevents oral hydration and nutrition, and can produce localized infection
r sepsis. This investigation reviews our experience treating postoperative esopha-
eal leaks with the Polyflex esophageal stent (Boston Scientific, Natick, Mass).
ethods: Over a 30-month period, patients with a postoperative esophageal leak
ere treated with the Polyflex stent for leak occlusion. Leak occlusion was con-
rmed by means of esophagraphy. Patients were followed until their stent was
emoved and their esophageal leak had resolved.
esults: Twenty-one patients had 27 stents placed for leak occlusion after esopha-
ectomy (n  5), esophageal perforation (n  5), surgical (n  4) or endoscopic
n  2) antireflux procedure, and esophageal diverticulectomy (n  3) or myotomy
n  2). The mean interval between surgical intervention and stent placement was
2  8 days (range, 3–31 days). Occlusion of the leak occurred in 20 patients. One
atient experienced a dehiscence of the surgical esophageal perforation repair
equiring esophageal diversion. Stent migration requiring repositioning (n  3) or
eplacement (n  4) occurred in 5 (24%) patients. Twenty (95%) stents were
emoved without residual leak (mean, 51  43 days; range, 15–175 days). One
atient had a stricture after stent removal that required endoscopic dilatation. One
atient in this series died.
onclusions: The Polyflex esophageal stent is an effective method for occluding a
ostoperative esophageal leak. It rapidly eliminates contamination of the mediastinum,
leura, and peritoneum; allows oral hydration and nutrition; and is easily removable.
hese stents also offer an appealing alternative to traditional esophageal diversion
nd subsequent reconstruction in patients with a persistent esophageal leak.
eak after esophageal anastomosis or perforation repair can be a challenge for
the surgeon. Traditional therapy for a symptomatic postoperative esophageal
fistula has been operative repair or, if unsuccessful, esophageal diversion.
uch treatment prolongs hospitalization and significantly delays oral hydration and
utrition. In the case of subsequent unsuccessful repairs, esophageal diversion commits
he patient to further surgical intervention to re-establish foregut continuity.
Endoluminal esophageal stents have been available for many years and have
een used to palliate unresectable esophageal malignancies with dysphagia. Unfor-
unately, the characteristics of the material of which stents were made caused them
o be difficult to insert and remove and resulted in significant complications, such as
tent migration, fistula formation or enlargement, and bleeding. However, since
sophageal stents made of materials that make them easier to place and remove, are
ignificantly more flexible, and exert less radial force and remain occlusive have
ecome available, recent reports of their use to treat symptomatic esophageal
nastomotic leak after cancer resection have been published.1,2 This investigation
eviews our experience treating recalcitrant postoperative esophageal fistulae endo-
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TScopically using an occlusive, silicon-coated esophageal stent
Polyflex; Boston Scientific, Natick, Mass).
aterials and Methods
ver a 30-month period, patients who experienced a postoperative
sophageal leak at either of 2 tertiary-care hospitals were offered
articipation in an institutional review board–approved protocol
sing an endoluminal esophageal stent to treat their fistula, a use of
he Polyflex stent not currently recognized by the Food and Drug
dministration. Patients with a documented esophageal leak that
ad recurred after at least 1 operative repair were eligible for
articipation in this investigation. For the purposes of this inves-
igation, patients with an esophageal perforation or esophageal
alignancies not previously treated with surgical intervention
ere excluded. Also excluded from participation were patients
ith an anastomotic disruption or ischemic esophageal conduit
hat would necessitate esophageal diversion. The presence of an
sophageal fistula was documented and localized by means of
astrograffin esophagraphy, barium esophagraphy, or both before
ny treatment. Additionally, all patients being considered for stent
lacement underwent computer-aided tomographic imaging of the
eck, chest, and abdomen.
All esophageal stents were placed in the operating room by a
horacic surgeon using general endotracheal anesthesia and fluo-
oscopy after flexible esophagoscopy. Adequate drainage of in-
ected areas was also simultaneously achieved. Fistula occlusion
as confirmed by means of contrast esophagraphy a minimum of
8 hours after stent placement or when the patient was able to
articipate in the examination. In the absence of a continued leak,
atients who were able were begun on a “soft mechanical” diet
ithout bread or meat and advanced as tolerated to a “postgras-
rectomy” diet.
It was the intention to remove all patients’ esophageal stents
fter a sufficient amount of time to allow permanent fistula closure.
his was individualized based on the fistula cause, anatomic lo-
ation, nutritional status of the patient, and resolution of all asso-
iated infectious or septic parameters, including the resolution of
ny associated organ failure, but was not less than 14 days after
nitial stent placement. Stent removal again was carried out in the
perating room after achievement of general anesthesia. Flexible
sophagoscopy was performed before and after stent removal as
ell. An esophagraphy was again performed 24 hours after stent
emoval to exclude recurrent leak. Patients were followed until
heir esophageal fistula had resolved, their stent had been removed,
nd they were tolerating oral nutrition. All patients were assessed
t least 1 month after stent removal for dysphagia. Continuous data
or this investigation are expressed as the mean  standard devi-
tion of the mean, except where otherwise indicated.
esults
uring the 30-month study period, 29 patients were evalu-
ted by the authors at either of the 2 study institutions for a
ostoperative esophageal fistula. Twenty-two patients met
he investigation’s inclusion criteria; 1 of these patients
efused further intervention and was not included in this
eview. Thus 21 patients were available to participate.
ollow-up was complete in all of these 21 patients for the p
34 The Journal of Thoracic and Cardiovascular Surgery ● Febrtudy period. Their mean age was 58  20 years (range,
4–93 years). The causes of their esophageal fistulae were
sophagectomy (n  5), esophageal perforation repair (n 
), surgical antireflux procedure (n  4), esophageal divert-
culectomy (n  3), endoscopic antireflux procedure (n 
), and esophageal myotomy (n  2, Table 1). Five patients
ere seen in consultation as inpatients after their original
peration, and 16 patients were transferred from other hos-
itals before their evaluation. The mean number of at-
empted repairs before stent placement was 1.4  0.8
range, 1–4; median, 1). The mean number of days from
nitial surgical repair to stent placement was 12  8 days
range, 3–31 days). Twelve (57%) patients underwent ad-
itional procedures at the time of stent placement (Table 2),
he most common of which was for enteral feeding access.
Mean days from stent placement until repeat esopha-
raphy was 6  7 days (range, 2–29 days; median, 4 days).
he most common reason for delay of esophagraphy be-
ond 48 hours was continued mechanical ventilation. Oc-
lusion of the esophageal fistula occurred in 20 (95%)
able 1. Patient demographic
ge (y) Initial procedure
Attempted
operative repairs Fistula location
64 Esophagectomy 1 Pleura
59 Esophagectomy* 2 Trachea
51 Esophagectomy* 1 Bronchus
67 Esophagectomy* 1 Pleura
54 Esophagectomy* 1 Bronchus
44 Perforation repair 3 Cutaneous (neck)
93 Perforation repair 1 Peritoneum
69 Perforation repair 1 Pleura and
peritoneum
82 Perforation repair 1 Bronchus
84 Perforation repair 2 Mediastinum
34 Surgical antireflux 1 Peritoneum
48 Surgical antireflux 1 Mediastinum
39 Surgical antireflux 1 Peritoneum
49 Surgical antireflux 2 Pleura and
peritoneum
73 Diverticulectomy 1 Pleura
66 Diverticulectomy 1 Mediastinum
37 Diverticulectomy 2 Mediastinum
72 Endoscopic antireflux 1 Mediastinum
78 Endoscopic antireflux 1 Peritoneum
33 Esophageal myotomy 1 Peritoneum
14 Esophageal myotomy 4 Peritoneum and
pleura
rocedure, Initial surgical or endoscopic procedure; Attempted operative
epairs, number of surgical procedures to repair esophageal leak/fistula
efore stent placement; Fistula location, distal esophageal fistula site.
Received preoperative chemotherapy and external beam radiation
herapy.atients, as demonstrated by the initial esophagram. All 20
uary 2007
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G
TSatients were able to be started on an oral intake regimen, as
utlined above. Polyflex stents in 20 (95%) patients were
emoved without residual esophageal leak or fistula at a
ean of 51  43 days (range, 15–175 days). None of these
atients required further operations for their esophageal
stula. Hospital length of stay varied widely because of the
ause of the esophageal fistula and associated complica-
ions. The mean was 12  12 days (range, 4–44 days;
edian, 7 days).
All stent placements occurred without intraoperative
omplications. One patient experienced the dehiscence of
he esophageal perforation repair 2 days after stent place-
ent and required operative repair. Other associated mor-
idities included respiratory failure (n  5), pneumonia
n  2), and deep venous thrombosis (n  1), and 1 patient
equired celiotomy for an enterocutaneous fistula thought to
e related to the original abdominal operation (Table 3).
ne (5%) patient had an esophageal stricture after stent
emoval that required endoscopic dilatation. One (5%) pa-
ient died from the rupture of an infected thoracic aortic
raft after the reoperative repair of an aortic dissection
omplicated by esophageal perforation. This patient’s
sophageal injury was recognized and repaired by means of
rimary closure of the esophagus and pedicled muscle in-
erposition at the time of the aortic dissection repair. When
he leak recurred, endoluminal esophageal stent placement
as performed. This patient’s stent had been removed be-
ore death.
iscussion
he use of an endoluminal esophageal stent is not a new
oncept. Esophageal intubation has been used since the 19th
entury, when Symonds3 described his experience with
rostheses made of ivory and silver. In more recent times,
ousseau and Celestin, and Atkinson and Ferguson have all
eveloped devices for esophageal intubation.4-6 Difficulty
ith insertion, migration, and extraction, however, limited
he use of these prostheses to the palliation of unresect-
ble malignant conditions of the esophagus, with rare
able 2. Surgical procedures performed in addition to
sophageal stent placement
Associated surgical procedures
Tube jejunostomy 10
Tube thoracostomy 5
Percutaneous endoscopic gastroscopy 4
Thoracoscopic decortication 4
Tracheostomy 3
Celiotomy 2
Neck exploration 1
Total 29xceptions.7 p
The Journal of ThoracicTaking advantage of the technology used to make endo-
ascular stents, self-expanding metallic esophageal stents
ecame available in the 1990s. These stents could be in-
erted with flexible esophagoscopy, required significantly
ess esophageal dilatation, had a lower rate of migration,
nd provided excellent palliation for malignant esophageal
trictures.8 Subsequently, occlusive self-expanding esopha-
eal stents were used to treat patients with malignant tra-
heoesophageal fistulae, as well as esophageal obstruction.9
he silicone covering decreased tumor ingrowth while
orming an occlusive seal in the case of a fistula. However,
here continued to be reluctance to place these prostheses in
he esophagus of a patient for conditions other than pallia-
ive therapy for a malignancy because of the potential
sophageal damage associated with extraction.
The recent ability to produce a plastic prosthesis coated
ith silicone has resulted in an esophageal stent that has a
istinct advantage over previous versions. Ease of insertion,
he requirement for minimal esophageal dilation, and the
ormation of an occlusive seal within the lumen of the
sophagus are all similar to the self-expanding metallic
tents. The distinct advantage of these nonmetallic endopros-
heses is their unique ability to be extracted without damaging
he esophagus. This has led some investigators to implant these
tents in select patients as a temporary measure to treat an
sophageal leak or fistula after esophagectomy.10
Patients who experience a continued leak or have an
sophageal fistula after initial repair of an esophageal per-
oration or anastomotic dehiscence will most often experi-
nce a prolonged hospital course, realize a significant delay
n their ability to take oral nutrition and hydration, and have
he potential to experience localized infectious complica-
ions, as well as sepsis. The traditional treatment for these
atients has been a reoperative attempt at repair or esoph-
geal diversion with or without esophagectomy. On the
asis of our anecdotal experiences using an occlusive,
ilicone-coated esophageal stent (Polyflex), we hypothe-
ized that temporary esophageal stent placement could ef-
ectively treat some postoperative esophageal fistulae with-
ut the need for further esophageal operations.
This investigation reviews our experiences with a large
roup of patients treated in this manner. We found that
ndoluminal esophageal stent placement was easily accom-
able 3. Morbidities occurring after stent placement
Morbidities
Stent migration 5 (24%)
Respiratory failure 3 (14%)
Pneumonia 2 (10%)
Deep venous thrombosis 1 (5%)
Enterocutaneous fistula 1 (5%)lished. This resulted in the rapid closure of postoperative
and Cardiovascular Surgery ● Volume 133, Number 2 335
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G
TSsophageal fistulae, eliminating this source of infection/
epsis in all but 1 patient in this series. Although some
atients could not attempt oral nutrition because of comor-
id processes, patients who could otherwise tolerate an oral
iet began one significantly sooner than would be expected
fter operative fistula repair. Finally, although difficult to
uantify, it would appear that the 20 patients who were
uccessfully treated with esophageal stent placement should
ave benefited from a reduction in the potential morbidity
ssociated with another major surgical procedure. Similarly,
small percentage of these 20 patients could have required
sophageal diversion with subsequent reconstruction, nei-
her of which was realized because of endoluminal therapy.
These results are in keeping with 2 smaller series of
atients with a postoperative esophageal anastomotic leak
ho received esophageal stent placement instead of opera-
ive repair.11,12 However, the current series is unique in both
ts size and the treatment algorithm used. Both previously
eported series each contained significantly fewer patients
han the series presented in this investigation. Furthermore,
either of the cited series treated a postoperative esophageal
stula definitively with surgical intervention, as was our
tandard, followed by endoluminal esophageal stent place-
ent only if the fistula recurred. This strategy reflects the likely
reference of the majority of thoracic surgeons and identifies a
iable alternative to further surgical intervention.
The migration of these stents does minimally detract
rom their use. In this review 7 stents migrated in 5 patients,
equiring repositioning or replacement. This compares fa-
orably with other series in which esophageal stents have
een used to palliate malignant strictures.13 However, we
ave recognized that this can be minimized by slightly
versizing the diameter and significantly oversizing the
ength of the stent when possible. Migration in our series
as also more common in the proximal cervical esophagus
nd at the gastroesophageal junction, as would be expected
ecause of the decreased surface area of the esophagus
vailable to seat the stent.
Esophageal stricture formation after stent removal also
ccurred in 1 (5%) patient in this investigation. This has
een reported previously and appears to occur most often if
he leak being treated is at the site of an esophagogastros-
omy. In the series by Langer and colleagues,2 as well as in
ur experience, such strictures are easily treated without
urther surgical intervention and should not detract signifi-
antly from the use of these stents.
Similarly important to the success of treating patients
ith a postoperative esophageal fistula by using an esoph-
geal stent is to achieve the same goals one would entertain
f operative repair was performed. In addition to fistula
cclusion, these include eliminating sources of infection/
epsis, establishing reliable access for enteral nutrition, and
inimizing postoperative morbidity. In this series patients
36 The Journal of Thoracic and Cardiovascular Surgery ● Febrequired an average of 1.4 simultaneous procedures to ac-
omplish these goals. We believe these associated proce-
ures were integral to whatever success we might have
chieved. In our opinion this global approach to these pa-
ients can only be provided with the involvement of and
referably under the direction of a thoracic surgeon.
Although it would appear that endoluminal esophageal
tent placement for postoperative esophageal fistulae could
ave some advantages over further attempts at operative
epair, this investigation has some weaknesses. Although
epresenting the largest number of postoperative esophageal
stulae treated in this manner in the current literature, a
atient population of 21 remains a small number, even for a
elatively uncommon condition. Furthermore, no attempt
as made to compare endoluminal therapy with reoperative
herapy in either a prospective or retrospective fashion. It
as believed that such a comparison would be of minimal
enefit because of the significant variation in patients’ co-
orbidities at the time the fistula was recognized, as well as
he varied nature of their underlying esophageal diseases.
In conclusion, this series demonstrates the effectiveness
f an occlusive esophageal stent in treating patients with
ecalcitrant postoperative esophageal fistulae. Endoluminal
tent placement provides rapid fistula closure, eliminating
oilage of the mediastinum, pleura and, peritoneum; allows
atients to begin oral intake within 48 hours of stent place-
ent; and eliminates the need for further operations in the
ast majority of patients. Stent placement also offers an
ppealing alternative to reoperative repair and especially
sophageal diversion and subsequent reconstruction. Proper
atient selection and stent sizing should minimize the prin-
iple weakness of this treatment strategy: stent migration.
he initial success demonstrated by this review might hold
romise for treating selected postoperative esophageal fis-
ulae, as well as iatrogenic esophageal perforations, with
ndoluminal techniques.
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iscussion
r Henning A. Gaissert (Boston, Mass). I have no disclosures.
To summarize, Dr Freeman and associates report 21 patients in
hom acute postoperative esophageal leaks of fistulae were treated
ith a self-expanding Polyflex stent after failure of at least 1
perative repair. A seal was achieved in 20 of these 21 patients,
nd stenting lasted for a mean of 51 days. There were 3 compli-
ations. One patient died from disruption of an aortic repair, 1
atient had disruption of an esophageal repair, and 1 patient had a
tricture.
I have 2 comments and several questions. The first point is that
uccessful sealing of the leak is gratifying and important, but it is
ot the complete management of an esophageal leak. Other im-
ortant components are the drainage of extraluminal fluid collec-
ions, decortication for pleural sepsis, and separation of the esoph-
gus from adjacent structures, such as the aorta or airway, with
ascularized tissue.
The second point is that self-expanding stents have important
isadvantages related to the radial force necessary to maintain their
osition. If this radial force is too high, the stent erodes the mucosa
nd causes ulceration and stricture, and if it is too low, the stent
lips and migrates, which occurred in 24% of patients. Placed
cross the esophagogastric junction, the stent might cause debili-
ating reflux and a stricture above. This treatment is therefore not
ithout complications.
Now to my questions. There were 29 patients in the 2½ years
ith postoperative esophageal leaks and fistulae. I realize many of
hese were referred to you, but is there anything that you have
earned in this period from the primary repair that would lead you
o improve that management to decrease the need for stent inter-
ention?
Second, do you trust the scar that results from stenting alone?
note that one of your patients had an erosion after an aortic repair
hrough the aortic suture line, and there were 4 patients with
irway fistulae, and I wonder whether in each of these patients you
imply trusted the scar caused or occasioned after stent placement.
Third, there was an average of 6 days that passed before you
new whether the stent sealed the hole. That is a long time not
nowing whether your management succeeded. Would you con-
ider obtaining contrast studies at the time of stent placement? t
The Journal of ThoracicThis was a very nice article and very well presented, and I
hank the Association for the opportunity to discuss it.
Dr Freeman. Thank you, Dr Gaissert.
You are correct in that only 3 of these patients came from our
ractice. The remaining patients either came from a gastroenter-
logist at our institution or were transferred in 16 cases. I think that
ooking at these patients brings to light the things that we are
aught, that repairs should try and be without tension and to have
ome kind of vascularized tissue applied to them. We usually use
uscle. In some of these patients, this had not been done initially
nd might have contributed to the failure.
As far as trusting the repair, we have had no problems with
ecurrent fistulae. That being said, 51 days was our mean time until
tent removal, and I think we were very leery of taking these out
oo soon. In fact, we wanted to see excellent nutritional parameters
n the patient and resolution of any infectious or septic parameter,
ncluding resolution of associated organ failure. Therefore I think
e were very conservative when we removed these, and hopefully
hat has contributed to the lack of recurrence.
As far as knowing that the stent had sealed, to be honest with
ou, I think we have a pretty good idea of that at the time of stent
lacement. Because we were doing a study, we wanted a contrast
sophagram for every patient. However, after stent placement, we
bviously would perform another flexible esophagoscopy and
ould insufflate, and you get a pretty good idea that the leak has
ealed if you have a chest tube in place, or if you have an airway
stula, you are going to do a bronchoscopy at the same time.
herefore I think some of the esophagrams were delayed because
f the patients’ other comorbidities, but in general, we usually
new that we had a good seal on leaving the operating room.
Dr Jonathan C. Nesbitt (Nashville, Tenn). Richard, I enjoyed
our presentation. This is a difficult problem in a select cohort of
atients, and I congratulate you on your results.
Dr Gaissert mentioned the problem with migration, and cer-
ainly I think with this particular stent it is one of the biggest
ssues, and, as you have shown, 24%, that is a relatively high rate.
How do you size the stent, not only the diameter but also the
ength? Also, with regard to the actual perforation or the fistula,
hat do you believe is the optimal position, either high or low, in
he esophagus for this particular stent? That is my first question.
Dr Freeman. We tend to oversize the diameter of the stent
lightly and the length significantly, and we do that at the time of
ndoscopy by insufflating and also by using fluoroscopy. There-
ore it is more of a feel. It also depends on where the fistula is
ocated. Obviously you cannot do that if it is extremely proximal
r extremely distal.
Dr Nesbitt. Certainly you cannot because the sizes vary sig-
ificantly, and there is quite a difference between the diameters of
ach stent. The stents might slide and migrate, and sealing of the
stula or perforation is directly related to the stability of the stent
osition.
Dr Freeman. This article does not address acute perforations,
ut in these patients who have all had operations and some sort of
epair, they do have more scarring, and I think you have a little bit
f an advantage in that respect.
Dr Nesbitt. My next question pertains to the disparity between
emoval times of the stents. What do you believe is the optimal
ime for removal?
and Cardiovascular Surgery ● Volume 133, Number 2 337
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TSDr Freeman. Again, that is a very individualized decision. We
ere very conservative and still are. We like to see positive
itrogen balance, a good prealbumin value, resolution of any
nfectious or septic problems, and obviously no other signs of leak.
e have had several persons in this series in whom we could
ctually monitor the healing either because it was an airway fistula
r in one case a cervical esophagocutaneous fistula, and that made
t a little easier, but it is a very individualized decision and it is
ased mainly on the patient’s global status.
Dr Nesbitt. Finally, did you perform follow-up studies once
ou removed the stent, and if so, did you have any leaks, or did you
ave to replace the stent?
Dr Freeman. We performed esophagoscopy in the operating
oom before and after the removal of each stent, and a minimum
f 24 to 48 hours after stent removal, the patients had another
ontrast esophagram. No patient had a residual leak or fistula in
his series.
Dr Bryan F. Meyers (St Louis, Mo). Congratulations on your
rticle.
You mentioned oversizing, and with these stents, if you over-
ize them too much, then you get an infolding at the top of the stent
hat is difficult to pop out, and then you are forced to stick a dilator
r a balloon down there and blow up a balloon in a perforated or
eaking esophagus. I just wondered whether you have encountered
hat problem. And just following up on the last question, how
pecifically would you pick the size to make it not migrate but
ake it not so large that you end up with an infolding and more of
tendency to leak around it?
Dr Freeman. In general, getting back to size, you really get a
eel when you insufflate and distend the esophagus, and we gen-
rally go very large to make sure we have enough radial force to
eal this, and I do not think we have used anything smaller than a38 The Journal of Thoracic and Cardiovascular Surgery ● Febrrustrating problem. In early patients we would try and use a
alloon dilator. The last few times that has happened, I basically
eft it alone and then did another examination in about 24 to 48
ours, and the fold comes out and opens up over time as the stent
arms up.
Dr Rafael S. Andrade (Minneapolis, Minn). I commend you
or trying to shift the therapeutic paradigm to this problem.
I have a question for you in terms of the esophagram. We have
een, particularly after an anastomotic leak, that the esophagram is
egative in the upright position, but in the supine position contrast
rickles distally around the stent and out of the fistula. Now, that is
ot necessarily a failure because you might still be slowing down
he leak and eventually the patient will do well. I want to have your
pinion on how you are doing your esophagrams after stent place-
ent.
Dr Freeman. First of all, I think that hopefully has been a
inimal problem because we do oversize significantly in diameter
f the stent. We do wait generally a minimum of 48 hours before
e do an esophagram, and they do a standard esophagram, which
s sitting and lying down, and it is a video esophagram.
Dr Stephen G. Swisher (Houston, Tex). As you know, there is
variation in severity of esophageal leaks, and I was just wonder-
ng whether you could comment on how many of these leaks were
ontained and how many were free flowing, and how many of
hese patients were septic or were looking pretty good?
Dr Freeman. One indication of how sick they were is that most
f them were transferred from other places. They were critically
ll. Their leaks were, for the most part, drained, at least into the
leural or peritoneal space. These were not small, contained post-
perative leaks that just needed a few more days to heal. These
ere fairly significant leaks, and I think you can tell that also by
he associated procedures that we had to do to try and remove areas
ize 25 in these patients. As far as the folding, that is a very of infection.
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